Quantitative Assessment of Combination Antimicrobial Therapy against Multidrug‐Resistant Bacteria in a Murine Pneumonia Model
Author(s) -
Zhe Yuan,
Kimberly R. Ledesma,
Renu Singh,
Jingguo Hou,
Randall A. Prince,
Vincent H. Tam
Publication year - 2010
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/651024
Subject(s) - antimicrobial , acinetobacter baumannii , cefepime , pseudomonas aeruginosa , antibiotics , multiple drug resistance , pneumonia , amikacin , microbiology and biotechnology , medicine , antibiotic resistance , combination therapy , biology , bacteria , pharmacology , imipenem , genetics
Combination antimicrobial therapy is clinically used as a last-resort strategy to control multidrug-resistant bacterial infections. However, selection of antibiotics is often empirical, and conventional assessment of combined drug effect has not been correlated to clinical outcomes. Here, we report a quantitative method to assess combined killing of antimicrobial agents against 2 multidrug-resistant bacteria.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom